AVITA Medical (RCEL) Net Income towards Common Stockholders Growth (1y) (2019 - 2025)
AVITA Medical (RCEL) Net Income towards Common Stockholders Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | AVITA Medical | 109.91 Mn | 91.73 Mn | 14.31 Mn | -0.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.39% |
| Sep 30, 2025 | 18.62% |
| Jun 30, 2025 | 35.56% |
| Mar 31, 2025 | 25.72% |
| Dec 31, 2024 | -130.77% |
| Sep 30, 2024 | -86.01% |
| Jun 30, 2024 | -48.24% |
| Mar 31, 2024 | -102.36% |
| Dec 31, 2023 | 785.60% |
| Sep 30, 2023 | -55.91% |
| Mar 31, 2023 | 2.57% |
| Sep 30, 2022 | 6.05% |
| Mar 31, 2022 | -57.80% |
| Sep 30, 2021 | 41.84% |
| Jun 30, 2021 | 63.47% |
| Mar 31, 2021 | 60.15% |
| Dec 31, 2020 | 46.29% |
| Sep 30, 2020 | -186.79% |
| Jun 30, 2020 | -69.48% |
| Mar 31, 2020 | -143.42% |